Literature DB >> 19759027

Identification of the GATA factor TRPS1 as a repressor of the osteocalcin promoter.

Denise M Piscopo1, Eric B Johansen, Rik Derynck.   

Abstract

A proteomic analysis of proteins bound to the osteocalcin OSE2 sequence of the mouse osteocalcin promoter identified TRPS1 as a regulator of osteocalcin transcription. Mutations in the TRPS1 gene are responsible for human tricho-rhino-phalangeal syndrome, which is characterized by skeletal and craniofacial abnormalities. TRPS1 has been shown to bind regulatory promoter sequences containing GATA consensus binding sites and to repress transcription of genes involved in chondrocyte differentiation. Here we show that TRPS1 can directly bind the osteocalcin promoter in the presence or absence of Runx2. TRPS1 binds through a GATA binding sequence in the proximal promoter of the osteocalcin gene. The GATA binding site is conserved in mice, humans, and rats, although its location and orientation are not. Mutation of the mouse or human GATA binding sequence abrogates binding of TRPS1 to the osteocalcin promoter. We show that TRPS1 is expressed in osteosarcoma cells and upon induction of osteoblast differentiation in primary mouse bone marrow stromal cells and that TRPS1 regulates the expression of osteocalcin in both cell types. The expression of TRPS1 modulates mineralized bone matrix formation in differentiating osteoblast cells. These data suggest a role for TRPS1 in osteoblast differentiation, in addition to its previously described role in chondrogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19759027      PMCID: PMC2797240          DOI: 10.1074/jbc.M109.052316

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  70 in total

Review 1.  Runx2: a master organizer of gene transcription in developing and maturing osteoblasts.

Authors:  Tania M Schroeder; Eric D Jensen; Jennifer J Westendorf
Journal:  Birth Defects Res C Embryo Today       Date:  2005-09

2.  Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts.

Authors:  T Komori; H Yagi; S Nomura; A Yamaguchi; K Sasaki; K Deguchi; Y Shimizu; R T Bronson; Y H Gao; M Inada; M Sato; R Okamoto; Y Kitamura; S Yoshiki; T Kishimoto
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

3.  Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation.

Authors:  P Ducy; R Zhang; V Geoffroy; A L Ridall; G Karsenty
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

4.  Mutations and promoter SNPs in RUNX2, a transcriptional regulator of bone formation.

Authors:  Dobrawa Napierala; Xavier Garcia-Rojas; Kathy Sam; Keiko Wakui; Connie Chen; Roberto Mendoza-Londono; Guang Zhou; Qiping Zheng; Brendan Lee
Journal:  Mol Genet Metab       Date:  2005 Sep-Oct       Impact factor: 4.797

Review 5.  Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone.

Authors:  J Pratap; J B Lian; A Javed; G L Barnes; A J van Wijnen; J L Stein; G S Stein
Journal:  Cancer Metastasis Rev       Date:  2006-12       Impact factor: 9.264

6.  The tissue-specific nuclear matrix protein, NMP-2, is a member of the AML/CBF/PEBP2/runt domain transcription factor family: interactions with the osteocalcin gene promoter.

Authors:  H L Merriman; A J van Wijnen; S Hiebert; J P Bidwell; E Fey; J Lian; J Stein; G S Stein
Journal:  Biochemistry       Date:  1995-10-10       Impact factor: 3.162

7.  Transforming growth factor-beta (TGF-beta)-induced down-regulation of cyclin A expression requires a functional TGF-beta receptor complex. Characterization of chimeric and truncated type I and type II receptors.

Authors:  X H Feng; E H Filvaroff; R Derynck
Journal:  J Biol Chem       Date:  1995-10-13       Impact factor: 5.157

8.  A PEBP2 alpha/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element.

Authors:  V Geoffroy; P Ducy; G Karsenty
Journal:  J Biol Chem       Date:  1995-12-29       Impact factor: 5.157

9.  In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector.

Authors:  L Naldini; U Blömer; P Gallay; D Ory; R Mulligan; F H Gage; I M Verma; D Trono
Journal:  Science       Date:  1996-04-12       Impact factor: 47.728

10.  MoD Tools: regulatory motif discovery in nucleotide sequences from co-regulated or homologous genes.

Authors:  Giulio Pavesi; Paolo Mereghetti; Federico Zambelli; Marco Stefani; Giancarlo Mauri; Graziano Pesole
Journal:  Nucleic Acids Res       Date:  2006-07-01       Impact factor: 16.971

View more
  25 in total

1.  Molecular Validation of PACE4 as a Target in Prostate Cancer.

Authors:  François D'Anjou; Sophie Routhier; Jean-Pierre Perreault; Alain Latil; David Bonnel; Isabelle Fournier; Michel Salzet; Robert Day
Journal:  Transl Oncol       Date:  2011-06-01       Impact factor: 4.243

2.  Genetic variation in TRPS1 may regulate hip geometry as well as bone mineral density.

Authors:  Cheryl L Ackert-Bicknell; Serkalem Demissie; Shirng-Wern Tsaih; Wesley G Beamer; L Adrienne Cupples; Beverly J Paigen; Yi-Hsiang Hsu; Douglas P Kiel; David Karasik
Journal:  Bone       Date:  2012-01-28       Impact factor: 4.398

Review 3.  Genetics of aging bone.

Authors:  Douglas J Adams; David W Rowe; Cheryl L Ackert-Bicknell
Journal:  Mamm Genome       Date:  2016-06-06       Impact factor: 2.957

4.  Trps1 transcription factor regulates mineralization of dental tissues and proliferation of tooth organ cells.

Authors:  Morgan Goss; Mairobys Socorro; Daisy Monier; Kostas Verdelis; Dobrawa Napierala
Journal:  Mol Genet Metab       Date:  2019-01-23       Impact factor: 4.797

5.  Atypical GATA protein TRPS1 plays indispensable roles in mouse two-cell embryo.

Authors:  Yue Liu; Songhua Xu; Xiuli Lian; Yang Su; Yuhuan Zhong; Ruimin Lv; Kaien Mo; Huimin Zhu; Wang Xiaojiang; Lixuan Xu; Shie Wang
Journal:  Cell Cycle       Date:  2019-02-12       Impact factor: 4.534

6.  Dual role of the Trps1 transcription factor in dentin mineralization.

Authors:  Maria Kuzynski; Morgan Goss; Massimo Bottini; Manisha C Yadav; Callie Mobley; Tony Winters; Anne Poliard; Odile Kellermann; Brendan Lee; Jose Luis Millan; Dobrawa Napierala
Journal:  J Biol Chem       Date:  2014-08-15       Impact factor: 5.157

7.  Identification of Novel Potentially Pleiotropic Variants Associated With Osteoporosis and Obesity Using the cFDR Method.

Authors:  Yuan Hu; Li-Jun Tan; Xiang-Ding Chen; Zhen Liu; Shi-Shi Min; Qin Zeng; Hui Shen; Hong-Wen Deng
Journal:  J Clin Endocrinol Metab       Date:  2018-01-01       Impact factor: 5.958

8.  Trps1 activates a network of secreted Wnt inhibitors and transcription factors crucial to vibrissa follicle morphogenesis.

Authors:  Katherine A Fantauzzo; Angela M Christiano
Journal:  Development       Date:  2011-11-24       Impact factor: 6.868

9.  Expression and relevance of TRPS-1: a new GATA transcription factor in breast cancer.

Authors:  Jie Qing Chen; Yi Bao; Jennifer Litton; Li Xiao; Hua-Zhong Zhang; Carla L Warneke; Yun Wu; Xiaoyun Shen; Sheng Wu; Ruth L Katz; Aysegul Sahin; Melissa Bondy; James L Murray; Laszlo Radvanyi
Journal:  Horm Cancer       Date:  2011-04       Impact factor: 3.869

10.  Identifying potentially common genes between dyslipidemia and osteoporosis using novel analytical approaches.

Authors:  Xu Lin; Cheng Peng; Jonathan Greenbaum; Zhang-Fang Li; Ke-Hao Wu; Zeng-Xin Ao; Tong Zhang; Jie Shen; Hong-Wen Deng
Journal:  Mol Genet Genomics       Date:  2018-01-11       Impact factor: 3.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.